Purine Club Annual Meeting ABSTRACT BOOK

Total Page:16

File Type:pdf, Size:1020Kb

Purine Club Annual Meeting ABSTRACT BOOK ISTITUTO SUPERIORE DI SANITÀ Purine Club Annual Meeting Istituto Superiore di Sanità Rome, 23-24 September, 2004 ABSTRACT BOOK Edited by Patrizia Popoli (a) and Gloria Cristalli (b) (a) Dipartimento del Farmaco, Istituto Superiore di Sanità, Rome (b) Dipartimento di Scienze Chimiche, Università di Camerino, Camerino ISSN 0393-5620 ISTISAN Congressi 04/C3 Istituto Superiore di Sanità Purine Club Annual Meeting. Istituto Superiore di Sanità. Rome, 23-24 September 2004. Abstract book. Edited by Patrizia Popoli and Gloria Cristalli 2004, vii, 48 p. ISTISAN Congressi 04/C3 The meeting is jointly organized by the Istituto Superiore di Sanità and the Purine Club. The main aim of the annual meetings of the Purine Club is to provide a forum for discussion and to allow collaborations between scientists working in the fields of chemistry, pharmacology and functions of purines. This 2004 meeting includes two authoritative lectures focused on the “fine tuning” by adenosine receptors in the brain and on the regulation of P2X receptors by hypoxia, respectively. The first session of oral communications covers the field of the Central Nervous System effects of purines, while the second one is focused on the pharmacology and functions of P2 receptors. Several other aspects (e.g., synthesis and SAR profile of purine derivatives, expression and functions of P1 and P2 receptors in central and peripheral tissues) are covered as well by the poster session. Key words: Purines, Chemistry, Pharmacology, Functional effects Istituto Superiore di Sanità Riunione annuale Purine Club. Istituto Superiore di Sanità. Roma, 23-24 settembre 2004. Riassunti. A cura di Patrizia Popoli e Gloria Cristalli 2004, vii, 48 p. ISTISAN Congressi 04/C3 (in English) Il convegno è organizzato congiuntamente dall’Istituto Superiore di Sanità e dal Purine Club. L’obiettivo principale dei meeting annuali del Purine Club è quello di favorire gli scambi e di promuovere la collaborazione tra i ricercatori impegnati nello studio della chimica, della farmacologia e degli effetti funzionali delle purine. Questo meeting 2004 comprende due autorevoli letture riguardanti rispettivamente il “fine tuning” esercitato dai recettori dell’adenosina sul sistema nervoso centrale e la regolazione dei recettori P2X da parte di condizioni di ipossia/ischemia. La prima sessione di comunicazioni orali è dedicata agli effetti delle purine sul sistema nervoso centrale, mentre la seconda alla farmacologia ed alle funzioni dei recettori P2. Diversi altri aspetti (come la sintesi ed il profilo struttura-attività dei derivati purinici, o le funzioni dei recettori P1 e P2 a livello centrale e periferico) sono affrontati nell’ambito della sessione poster. Parole chiave: Purine, Chimica, Farmacologia, Effetti funzionali Scientific Committee Gloria Cristalli (Università degli Studi di Camerino), Patrizia Popoli (Istituto Superiore di Sanità) Scientific Secretariat Mariangela Galluzzo, Rosa Grieco (Istituto Superiore di Sanità) Editing: Federica Magnani Per informazioni su questo documento scrivere a: [email protected]. Il rapporto è disponibile online sul sito di questo Istituto: www.iss.it. Presidente dell’Istituto Superiore di Sanità e Direttore responsabile: Enrico Garaci Registro della Stampa - Tribunale di Roma n. 131/88 del 1° marzo 1988 Redazione: Paola De Castro e Sandra Salinetti La responsabilità dei dati scientifici e tecnici è dei singoli autori. © 2004 Istituto Superiore di Sanità (Viale Regina Elena, 299 - 00161 Roma) This meeting and this book are dedicated to the memory of our friend and colleague Stefano Sagratella (1952-2004). We are sure that Stefano, who loved pharmacology and thought us to love it as well, will appreciate to be remembered in such a way. Patrizia Popoli, Claudio Frank, Antonella Pèzzola, Maria Rosaria Domenici, Maria Teresa Tebano, Rosaria Reggio i ii TABLE OF CONTENTS Programme .................................................................................................................. v Lectures How adenosine receptors fine tune neurotransmission to protect the brain ................... 3 Modulation of P2X7 receptor-function by hypoxia/ischemia......................................... 4 First session Receptor-dependent and independent effects of nucleosides in the Central Nervous System....................................................................................... 5 Second session Pharmacology and functions of P2 receptors ................................................................. 13 Poster abstracts ........................................................................................................ 21 Authors’ index ........................................................................................................... 47 iii iv PROGRAMME Tuesday, September 23, 2004 11.00 Registration 13.00 Lunch 14.10 Welcome and opening remarks G. Cristalli, P. Popoli First session RECEPTOR-DEPENDENT AND INDEPENDENT EFFECTS OF NUCLEOSIDES IN THE CENTRAL NERVOUS SYSTEM Chairpersons: M. Morelli, F. Pedata 14.30 Involvement of ERK1/2 phosphorylation in 2-chloro-2’-deoxy-adenosine-induced apoptosis and cell cycle block of human astrocytoma cells S. Ceruti, A. Mazzola, E. Beltrami, M.P. Abbracchio 14.50 Short-term regulation of A2B adenosine receptor functioning by tumor necrosis factor alpha in human astroglial cells M.L. Trincavelli, D. Tuscano, I. Tonazzini, S. Ceruti, M.P. Abbracchio, A. Lucacchini, C. Martini 15.10 Adenosine A2A antagonists and Parkinson’s disease: new findings on parkinsonian tremor N. Simola, A.R. Carta, E. Tronci, A. Pinna, M. Morelli 15.30 Adenosine A2A receptors enable metabotropic glutamate 5 receptors (mGlu5R)-mediated effects in the rodent hippocampus M.R. Domenici, M.T. Tebano, A. Martire, R. Pepponi, J.F. Chen, M.A. Schwarzschild, M.C. Grò, P. Popoli 15.50 The role of adenosine A3 receptors during mild and severe “ischemic conditions” in rat hippocampal slices A. M. Pugliese, E. Coppi, R. Corradetti, F. Pedata 16.10 Coffee break v 16.30 Lecture How adenosine receptors fine tune neurotransmission to protect the brain J.A. Ribeiro Introduced by P. Popoli 17.30 Poster viewing 18.30 Assembly of the Society members 20.30 Social dinner Friday, September 24, 2004 Second Session PHARMACOLOGY AND FUNCTIONS OF P2 RECEPTORS Chairpersons: M.P. Abbracchio, F. Caciagli 9.00 P2Y4 receptor, from differentiation to death F. Cavaliere, S. Amadio, V. Nestola, N. D’Ambrosi , G. Sancesario, G. Bernardi, C. Volonté 9.20 P2Y1 receptor activation regulates oligodendrocytes progenitor migration and proliferation C. Agresti, M.E. Meomartini, S. Amadio, E. Ambrosiani, B. Serafini, C. Volonté, F. Aloisi, S. Visentin 9.40 Upregulation of ionophoric P2X6 in chronic heart failure: interaction with TNF-Į and potential role in myocardial cell death S. Ferrario, C. Banfi, O. De Vincenti, S. Ceruti, M. Fumagalli, A. Mazzola, N. D’Ambrosi, C. Volonté, P. Fratto, E. Vitali, A. Parolari, G. Polvani, P. Biglioli, E. Tremoli, M.P. Abbracchio 10.00 2-Alkynyladenosine phosphates as new ligands for the P2 platelet receptors S. Vittori, S. Costanzi, F. R. Portino, S. Taffi, R. Volpini, M. Cattaneo, G. Cristalli 10.20 Cloning, pharmacological characterization and distribution of the rat G-protein-coupled P2Y13 receptor M. Fumagalli, L. Trincavelli, D. Lecca, C. Martini, P. Ciana, M.P. Abbracchio 10.40 Coffee break vi 11.00 Lecture Modulation of P2X7 receptor function by hypoxia P. Illes Introduced by R. Ciccarelli 11.30 Discussion of posters 1-12 Chairpersons: F. Laghi-Pasini, S. Vittori, C. Volonté 12.30 Lunch 13.30 Discussion of posters 13-24 Chairpersons: R. Ciccarelli, C. Martini, M.T. Tebano 14.30 Concluding remarks G. Cristalli vii viii Lectures 1 2 HOW ADENOSINE RECEPTORS FINE TUNE NEUROTRANSMISSION TO PROTECT THE BRAIN Joaquim Alexandre Ribeiro Laboratory of Neurosciences and Institute of Pharmacology, IMM, Faculty of Medicine, University of Lisboa, Lisboa, Portugal Adenosine is released from insulted neurones and glial cells (1), and is consensually recognised as very important in the homeostasis of the cells, being once named “a signal of life”. It modulates the activity of the nervous system by acting pre- (by inhibiting or facilitating transmitter release), post-, and/or non-synaptically, through activation of physiologically important high affinity adenosine receptors (A1, A2A) as well as of a lower affinity receptors (A2B, A3), which might be relevant in pathological conditions. Adenosine uses very subtle manners to participate in these actions, it acts as a fine tuner between its own receptors and the receptors for other synaptic mediators. From these modulatory actions it is possible to anticipate potential therapeutic applications (e.g. 2), especially when these actions are mediated by high-affinity adenosine A2A receptors in regions where clear functions for this receptor have been identified. The A2A receptor is highly expressed in the striatopallidal GABAergic neurones and expressed in lower levels in other brain regions. A2B possesses low levels of expression in the brain. A3 has apparently intermediate levels of expression in the human cerebellum and hippocampus and low levels in most of the brain. The well known striatal A2A/D2 receptor interactions may offer new therapeutic basis for basal ganglia disorders, such as Parkinson’s disease and Huntington’s chorea, as well as for schizophrenia. Inhibition of D2 receptors in the ventral striatum seems to be associated with the antipsychotic effect of neuroleptics, while inhibition of dopamine
Recommended publications
  • The Hypotensive Effect of Activated Apelin Receptor Is Correlated with Β
    This is the accepted (postprint) version of the following article: Besserer-Offroy É, et al. (2018), Pharmacol Res. doi: 10.1016/j.phrs.2018.02.032, which has been accepted and published in its final form at https://www.sciencedirect.com/science/article/pii/S1043661817313804 The hypotensive effect of activated apelin receptor is correlated with β-arrestin recruitment Élie Besserer-Offroya,c,ORCID ID, Patrick Bérubéa,c, Jérôme Côtéa,c, Alexandre Murzaa,c, Jean-Michel Longpréa,c, Robert Dumainea, Olivier Lesurb,c, Mannix Auger-Messierb,ORCID ID, Richard Leduca,c,ORCID ID, Éric Marsaulta,c,*,ORCID ID, Philippe Sarreta,c* Affiliations a Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, CANADA J1H 5N4 b Department of Medicine, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, CANADA J1H 5N4 c Institut de pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, Québec, CANADA J1H 5N4 e-mail addresses [email protected] (ÉBO); [email protected] (PB); [email protected] (JC); [email protected] (AM); Jean- [email protected] (JML); [email protected] (RD); [email protected] (OL); [email protected] (MAM); [email protected] (RL); [email protected] (EM); [email protected] (PS) © 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This is the accepted (postprint) version of the following article: Besserer-Offroy É, et al. (2018), Pharmacol Res. doi: 10.1016/j.phrs.2018.02.032, which has been accepted and published in its final form at https://www.sciencedirect.com/science/article/pii/S1043661817313804 Corresponding Authors *To whom correspondence should be addressed: Philippe Sarret, Ph.D.; [email protected]; Tel.
    [Show full text]
  • GPCR Regulation of ATP Efflux from Astrocytes
    G PROTEIN-COUPLED RECEPTOR REGULATION OF ATP RELEASE FROM ASTROCYTES by ANDREW EDWARD BLUM Thesis advisor: Dr. George R. Dubyak Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Department of Physiology and Biophysics CASE WESTERN RESERVE UNIVERSITY May, 2010 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of _____________________________________________________ candidate for the ______________________degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. Dedication I am greatly indebted to my thesis advisor Dr. George Dubyak. Without his support, patience, and advice this work would not have been possible. I would also like to acknowledge Dr. Robert Schleimer and Dr. Walter Hubbard for their encouragement as I began my research career. My current and past thesis committee members Dr. Matthias Buck, Dr. Cathleen Carlin, Dr. Edward Greenfield, Dr. Ulrich Hopfer, Dr. Gary Landreth, Dr. Corey Smith, Dr. Jerry Silver have provided invaluable guidance and advice for which I am very grateful. A special thanks to all of the past and present
    [Show full text]
  • Dissection of Gtpase-Activating Proteins Reveals Functional Asymmetry in the COPI Coat of Budding Yeast Eric C
    © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs232124. doi:10.1242/jcs.232124 RESEARCH ARTICLE Dissection of GTPase-activating proteins reveals functional asymmetry in the COPI coat of budding yeast Eric C. Arakel1, Martina Huranova2,3,*, Alejandro F. Estrada2,*, E-Ming Rau2, Anne Spang2,‡ and Blanche Schwappach1,4,‡ ABSTRACT The COPI coat is formed by an obligate heptamer – also termed – α β′ ε β γ δ ζ The Arf GTPase controls formation of the COPI vesicle coat. Recent coatomer consisting of , , , , , and subunits, and is recruited structural models of COPI revealed the positioning of two Arf1 en bloc to membranes (Hara-Kuge et al., 1994). Fundamentally, the molecules in contrasting molecular environments. Each of these COPI coat mediates the retrograde trafficking of proteins and lipids pockets for Arf1 is expected to also accommodate an Arf GTPase- from the Golgi to the ER, and within intra-Golgi compartments activating protein (ArfGAP). Structural evidence and protein (Arakel et al., 2016; Beck et al., 2009; Pellett et al., 2013; Spang and interactions observed between isolated domains indirectly suggest Schekman, 1998). Several reports have also implicated COPI in that each niche preferentially recruits one of the two ArfGAPs known endosomal recycling and regulation of lipid droplet homeostasis to affect COPI, i.e. Gcs1/ArfGAP1 and Glo3/ArfGAP2/3, although (Aniento et al., 1996; Beller et al., 2008; Xu et al., 2017). only partial structures are available. The functional role of the unique Activation of the small GTPase Arf1 and its subsequent non-catalytic domain of either ArfGAP has not been integrated into membrane anchoring by exchanging GDP with GTP through a the current COPI structural model.
    [Show full text]
  • Allosteric Activation of the Nitric Oxide Receptor Soluble Guanylate Cyclase
    RESEARCH ARTICLE Allosteric activation of the nitric oxide receptor soluble guanylate cyclase mapped by cryo-electron microscopy Benjamin G Horst1†, Adam L Yokom2,3†, Daniel J Rosenberg4,5, Kyle L Morris2,3‡, Michal Hammel4, James H Hurley2,3,4,5*, Michael A Marletta1,2,3* 1Department of Chemistry, University of California, Berkeley, Berkeley, United States; 2Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States; 3Graduate Group in Biophysics, University of California, Berkeley, Berkeley, United States; 4Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, United States; 5California Institute for Quantitative Biosciences, University of California, Berkeley, Berkeley, United States Abstract Soluble guanylate cyclase (sGC) is the primary receptor for nitric oxide (NO) in mammalian nitric oxide signaling. We determined structures of full-length Manduca sexta sGC in both inactive and active states using cryo-electron microscopy. NO and the sGC-specific stimulator YC-1 induce a 71˚ rotation of the heme-binding b H-NOX and PAS domains. Repositioning of the b *For correspondence: H-NOX domain leads to a straightening of the coiled-coil domains, which, in turn, use the motion to [email protected] (JHH); move the catalytic domains into an active conformation. YC-1 binds directly between the b H-NOX [email protected] (MAM) domain and the two CC domains. The structural elongation of the particle observed in cryo-EM was †These authors contributed corroborated in solution using small angle X-ray scattering (SAXS). These structures delineate the equally to this work endpoints of the allosteric transition responsible for the major cyclic GMP-dependent physiological Present address: ‡MRC London effects of NO.
    [Show full text]
  • Rhodopsin-Cyclases for Photocontrol of Cgmp/Camp and 2.3 Å Structure of the Adenylyl Cyclase Domain
    ARTICLE DOI: 10.1038/s41467-018-04428-w OPEN Rhodopsin-cyclases for photocontrol of cGMP/cAMP and 2.3 Å structure of the adenylyl cyclase domain Ulrike Scheib1, Matthias Broser1, Oana M. Constantin 2, Shang Yang3, Shiqiang Gao3 Shatanik Mukherjee1, Katja Stehfest1, Georg Nagel3, Christine E. Gee 2 & Peter Hegemann1 1234567890():,; The cyclic nucleotides cAMP and cGMP are important second messengers that orchestrate fundamental cellular responses. Here, we present the characterization of the rhodopsin- guanylyl cyclase from Catenaria anguillulae (CaRhGC), which produces cGMP in response to green light with a light to dark activity ratio >1000. After light excitation the putative signaling state forms with τ = 31 ms and decays with τ = 570 ms. Mutations (up to 6) within the nucleotide binding site generate rhodopsin-adenylyl cyclases (CaRhACs) of which the double mutated YFP-CaRhAC (E497K/C566D) is the most suitable for rapid cAMP production in neurons. Furthermore, the crystal structure of the ligand-bound AC domain (2.25 Å) reveals detailed information about the nucleotide binding mode within this recently discovered class of enzyme rhodopsin. Both YFP-CaRhGC and YFP-CaRhAC are favorable optogenetic tools for non-invasive, cell-selective, and spatio-temporally precise modulation of cAMP/cGMP with light. 1 Institute for Biology, Experimental Biophysics, Humboldt-Universität zu Berlin, 10115 Berlin, Germany. 2 Institute for Synaptic Physiology, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany. 3 Department of Biology, Institute for Molecular Plant Physiology and Biophysics, Biocenter, Julius-Maximilians-University of Würzburg, Julius-von-Sachs-Platz 2, 97082 Würzburg, Germany. These authors contributed equally: Christine E.
    [Show full text]
  • The ATP-Releasing Maxi-Cl Channel: Its Identity, Molecular Partners, and Physiological/Pathophysiological Implications
    life Review The ATP-Releasing Maxi-Cl Channel: Its Identity, Molecular Partners, and Physiological/Pathophysiological Implications Ravshan Z. Sabirov 1,2,*, Md. Rafiqul Islam 1,3, Toshiaki Okada 1,4, Petr G. Merzlyak 1,2 , Ranokhon S. Kurbannazarova 1,2, Nargiza A. Tsiferova 1,2 and Yasunobu Okada 1,5,6,* 1 Division of Cell Signaling, National Institute for Physiological Sciences (NIPS), Okazaki 444-8787, Japan; rafi[email protected] (M.R.I.); [email protected] (T.O.); [email protected] (P.G.M.); [email protected] (R.S.K.); [email protected] (N.A.T.) 2 Institute of Biophysics and Biochemistry, National University of Uzbekistan, Tashkent 100174, Uzbekistan 3 Department of Biochemistry and Molecular Biology, Jagannath University, Dhaka 1100, Bangladesh 4 Veneno Technologies Co. Ltd., Tsukuba 305-0031, Japan 5 Department of Physiology, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan 6 Department of Physiology, School of Medicine, Aichi Medical University, Nagakute 480-1195, Japan * Correspondence: [email protected] (R.Z.S.); [email protected] (Y.O.); Tel.: +81-46-858-1501 (Y.O.); Fax: +81-46-858-1542 (Y.O.) Abstract: The Maxi-Cl phenotype accounts for the majority (app. 60%) of reports on the large- conductance maxi-anion channels (MACs) and has been detected in almost every type of cell, including placenta, endothelium, lymphocyte, cardiac myocyte, neuron, and glial cells, and in cells originating from humans to frogs. A unitary conductance of 300–400 pS, linear current-to- Citation: Sabirov, R.Z.; Islam, M..R.; voltage relationship, relatively high anion-to-cation selectivity, bell-shaped voltage dependency, Okada, T.; Merzlyak, P.G.; and sensitivity to extracellular gadolinium are biophysical and pharmacological hallmarks of the Kurbannazarova, R.S.; Tsiferova, Maxi-Cl channel.
    [Show full text]
  • Ablation of XP-V Gene Causes Adipose Tissue Senescence and Metabolic Abnormalities
    Ablation of XP-V gene causes adipose tissue PNAS PLUS senescence and metabolic abnormalities Yih-Wen Chena, Robert A. Harrisb, Zafer Hatahetc, and Kai-ming Choua,1 aDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202; bRichard Roudebush Veterans Affairs Medical Center and the Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202; and cDepartment of Biological and Physical Sciences, Northwestern State University of Louisiana, Natchitoches, LA 71497 Edited by James E. Cleaver, University of California, San Francisco, CA, and approved June 26, 2015 (received for review April 12, 2015) Obesity and the metabolic syndrome have evolved to be major DNA polymerase η (pol η) is a specialized lesion bypass poly- health issues throughout the world. Whether loss of genome merase that faithfully replicates across UV-induced cyclobutane integrity contributes to this epidemic is an open question. DNA pyrimidine dimers (9) to rescue stalled DNA replication forks polymerase η (pol η), encoded by the xeroderma pigmentosum from potential breakages and mutations. Defects in the gene (XP-V) gene, plays an essential role in preventing cutaneous cancer encoding pol η produce a variant form of the autosomal recessive caused by UV radiation-induced DNA damage. Herein, we demon- disease xeroderma pigmentosum (XP-V) (9). Patients with XP-V strate that pol η deficiency in mice (pol η−/−) causes obesity with are highly sensitive to sunlight and prone to cutaneous cancer (9). visceral fat accumulation, hepatic steatosis, hyperleptinemia, In addition to skin, pol η is expressed in most tissues (10). The hyperinsulinemia, and glucose intolerance.
    [Show full text]
  • Glycylglycine Plays Critical Roles in the Proliferation of Spermatogonial Stem Cells
    3802 MOLECULAR MEDICINE REPORTS 20: 3802-3810, 2019 Glycylglycine plays critical roles in the proliferation of spermatogonial stem cells BO XU1,2*, XIANG WEI1*, MINJIAN CHEN1,2*, KAIPENG XIE3,4, YUQING ZHANG1,2, ZHENYAO HUANG1,2, TIANYU DONG1,2, WEIYUE HU1,2, KUN ZHOU1,2, XIUMEI HAN1,2, XIN WU1 and YANKAI XIA1,2 1State Key Laboratory of Reproductive Medicine, Institute of Toxicology; 2Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166; 3Nanjing Maternity and Child Health Care Institute, 4Department of Women Health Care, Nanjing Maternity and Child Health Care Hospital, Obstetrics and Gynecology Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu 210004, P.R. China Received May 9, 2018; Accepted July 9, 2019 DOI: 10.3892/mmr.2019.10609 Abstract. Glial cell line-derived neurotrophic factor (GDNF) properties that distinguish stem cells from somatic cells, is critical for the proliferation of spermatogonial stem cells and SSCs are the only germline stem cells that can undergo (SSCs), but the underlying mechanisms remain poorly under- self-renewal division (1). The balance between proliferation stood. In this study, an unbiased metabolomic analysis was and differentiation is therefore essential to the normal function performed to examine the metabolic modifications in SSCs of SSCs and to maintain male fertility (2). following GDNF deprivation, and 11 metabolites were observed Glial cell line-derived neurotrophic factor (GDNF) is to decrease while three increased. Of the 11 decreased metab- secreted by Sertoli cells, and is an important factor in the olites identified, glycylglycine was observed to significantly cell fate determination of SSCs, which was identified in rescue the proliferation of the impaired SSCs, while no such the year 2000 (3).
    [Show full text]
  • The Role of the Chaperone CCT in Assembling Cell Signaling Complexes
    Brigham Young University BYU ScholarsArchive Theses and Dissertations 2020-07-21 The Role of the Chaperone CCT in Assembling Cell Signaling Complexes Nicole C. Tensmeyer Brigham Young University Follow this and additional works at: https://scholarsarchive.byu.edu/etd Part of the Physical Sciences and Mathematics Commons BYU ScholarsArchive Citation Tensmeyer, Nicole C., "The Role of the Chaperone CCT in Assembling Cell Signaling Complexes" (2020). Theses and Dissertations. 9192. https://scholarsarchive.byu.edu/etd/9192 This Dissertation is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected]. The Role of the Molecular Chaperone CCT in Assembling Cell Signaling Complexes Nicole C. Tensmeyer A dissertation submitted to the faculty of Brigham Young University in partial fulfillment of the requirements for the degree of Doctor of Philosophy Barry M. Willardson, Chair Josh L. Andersen John C. Price Pam Van Ry Department of Chemistry and Biochemistry Brigham Young University Copyright © 2020 Nicole C. Tensmeyer All Rights Reserved ABSTRACT The Role of the Molecular Chaperone CCT in the Assembly of Signaling Complexes Nicole C. Tensmeyer Department of Chemistry and Biochemistry, BYU Doctor of Philosophy In order to function, proteins must be folded into their native shape. While this can sometimes occur spontaneously, the process can be hindered by thermodynamic barriers, trapped intermediates, and aggregation prone hydrophobic interactions. Molecular chaperones are proteins that help client proteins or substrates overcome these barriers so that they can be folded properly.
    [Show full text]
  • Rho Family Gtpases and Rho Gefs in Glucose Homeostasis
    cells Review Rho Family GTPases and Rho GEFs in Glucose Homeostasis Polly A. Machin 1, Elpida Tsonou 1,2, David C. Hornigold 2 and Heidi C. E. Welch 1,* 1 Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK; [email protected] (P.A.M.); [email protected] (E.T.) 2 Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Cambridge CB22 3AT, UK; [email protected] * Correspondence: [email protected]; Tel.: +44-(0)1223-496-596 Abstract: Dysregulation of glucose homeostasis leading to metabolic syndrome and type 2 diabetes is the cause of an increasing world health crisis. New intriguing roles have emerged for Rho family GTPases and their Rho guanine nucleotide exchange factor (GEF) activators in the regulation of glucose homeostasis. This review summates the current knowledge, focusing in particular on the roles of Rho GEFs in the processes of glucose-stimulated insulin secretion by pancreatic β cells and insulin-stimulated glucose uptake into skeletal muscle and adipose tissues. We discuss the ten Rho GEFs that are known so far to regulate glucose homeostasis, nine of which are in mammals, and one is in yeast. Among the mammalian Rho GEFs, P-Rex1, Vav2, Vav3, Tiam1, Kalirin and Plekhg4 were shown to mediate the insulin-stimulated translocation of the glucose transporter GLUT4 to the plasma membrane and/or insulin-stimulated glucose uptake in skeletal muscle or adipose tissue. The Rho GEFs P-Rex1, Vav2, Tiam1 and β-PIX were found to control the glucose-stimulated release of insulin by pancreatic β cells.
    [Show full text]
  • Pharmacological Insight Into the Activation of the Human Neuropeptide FF2 Receptor
    Pharmacological insight into the activation of the human Neuropeptide FF2 receptor Franck Talmont, Remi Veneziano, Gilles Dietrich, Lionel Moulédous, Catherine Mollereau, Jean-Marie Zajac To cite this version: Franck Talmont, Remi Veneziano, Gilles Dietrich, Lionel Moulédous, Catherine Mollereau, et al.. Pharmacological insight into the activation of the human Neuropeptide FF2 receptor. Peptides, Else- vier, In press, 134, pp.170406. 10.1016/j.peptides.2020.170406. hal-02939290 HAL Id: hal-02939290 https://hal.archives-ouvertes.fr/hal-02939290 Submitted on 18 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Pharmacological insight into the activation of the human neuropeptide FF2 receptor Franck Talmont a,b, *, Remi Veneziano a,b , Gilles Dietrich c , Lionel Moul ´ edous a,b , Catherine Mollereau a,b , Jean-Marie Zajac a,b a CNRS, IPBS (Institut De Pharmacologie Et De Biologie Structurale) 205 Route De Narbonne, 31077 Toulouse, Cedex 4, France b Universit ´ e Paul Sabatier Toulouse III, F-31300 Toulouse, France c INSERM IRSD (Institut De Recherche En Sant ´ e Digestive) U1220, CHU Purpan Place Du Docteur Baylac, CS 60039 31024, Toulouse Cedex 3, France Keywords: G protein coupled receptor GPCR NPFF peptide NPFF 2 receptor Neuropeptide * Corresponding author at: CNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale) 205 route de Narbonne, 31077 Toulouse, Cedex 4, France.
    [Show full text]
  • The Orphan G Protein-Coupled Receptor GPR17: Its Pharmacology
    The orphan G protein - coupled receptor GPR17: its pharmacology and function in recombinant and primary cell expression systems Dissertation zur Erlangung des Doktorgrades (Dr. rer. nat.) der Mathematisch - Naturwissenschaftlichen Fakultät der Rheinischen Friedrich - Wilhelms - Universität Bonn vorgelegt von Katharina Anna Maria Simon aus Düren Bonn 2016 Angefertigt mit Genehmigung der Mathematisch - Naturwissenschaftlichen Fakultät der Rheinischen Friedrich - Wilhelms Universität Bonn. 1. Gutachter: Prof. Dr. Evi Kostenis 2. Gutachter: Prof. Dr. Klaus Mohr Tag der Promotion: 19.01.2017 Erscheinungsjahr: 2017 Meiner Familie Abstract I Abstract The reconstitution of myelin sheaths, so called remyelination, represents an innovative therapeutic goal in multiple sclerosis (MS), the most common inflammatory - demyelinating disease of the central nervous system (CNS). Recently, the orphan G protein - coup led receptor (GPCR) GPR17, which is predominantly expressed in ol i- godendrocytes, has been identified as inhibitor of oligodendroglial differentiation, a r- resting oligodendrocytes in an immature, non - myelinating stage. Moreover, GPR17 expression is upregulat ed in human MS tissues, suggesting a key role of this receptor during the remyelination impairment that occurs in MS. However, the downstream si g- naling pathway connecting GPR17 to oligodendroglial maturation arrest is still poorly understood. The present work confirms that GPR17 activation by the small molecule agonist MDL29,9 51 results in a reduction of mature oligodendrocytes in vitro, evident by their decreased intracellular myelin basic protein (MBP) levels. The GPR17 - mediated mat u- ration block is cruci ally triggered by the Gα i/o pathway, which leads to an inhibition of two signaling cascades: (i) the adenylyl cyclase (AC) - cyclic adenosine monophosphate (cAMP) – protein kinase A (PKA) – cAMP response element - binding protein (CREB), and (ii) the AC - cAMP - excha nge protein directly activated by cAMP (EPAC).
    [Show full text]